{
  "url": "https://www.law.cornell.edu/regulations/new-york/18-NYCRR-505.3",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 18 ยง 505.3 - Drugs",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 18 ยง 505.3 - Drugs\n\nState Regulations\n(a) Definitions. (1)\n\nCompounded prescription\nmeans one in which two or more\ningredients are mixed by the dispensing pharmacist. Medical assistance\nreimbursement for compounding is limited to the following: (i) a combination of any two or more legend\ndrugs found on the list of Medicaid reimbursable prescription drugs; or\n(ii)\na combination of any legend\ndrugs included on the list of Medicaid reimbursable prescription drugs and any\nother item(s) not commercially available as an ethical or proprietary\nproduct(s); or\n(iii)\na combination\nof two or more products which are labeled \"Caution: For Manufacturing Purposes\nonly.\" The reconstitution of a commercially available drug is not a compounded\nprescription. (2)\n\nDrug\nmeans both prescription and nonprescription\ndrugs. (3)\n\nDrug acquisition\ncosts\nmeans the invoice price to the pharmacy of a prescription drug\ndispensed to a Medicaid recipient, minus the amount of all discounts and other\ncost reductions attributable to such dispensed drug. (4)\n\nNonprescription drug\nmeans any drug for which a prescription is not required under section\n6810\nof the\n\nEducation Law, including over the counter, pre-packaged items. (5)\n\nPractitioner\nmeans a\nperson licensed, authorized or otherwise permitted to write a\nprescription. (6)\n\nPrescription drug\nmeans any drug for which a prescription is\nrequired under section\n6810\nof the\n\nEducation Law. (7)\n\nWritten\norder\nor\nfiscal order\nare terms which are used\ninterchangeably in this section and refer to any original, signed written order\nof a practitioner including any faxed transmitted order which requests a\npharmacy to provide a drug to a medical assistance recipient. All written\norders and fiscal orders shall comply with the provisions of section\n21\nof the\n\nPublic Health Law and regulations promulgated thereunder or contained in this\nsection including but not limited to requirements for prescribing brand\nnecessary drugs. (b) Written order required. (1)\n\nDrugs may be obtained only upon the written order of a practitioner, except for\nnon-prescription emergency contraceptive drugs as described in subparagraph (i)\nof this paragraph, and for telephone and electronic orders for drugs filled in\ncompliance with this section and 10 NYCRR Part\n910. (i) Non-prescription emergency contraceptive\ndrugs for females may be obtained without a written order subject to a\nutilization frequency limit of 6 courses of treatment in any 12-month\nperiod. (ii)\n\nThe\nordering/prescribing of drugs is limited to the practitioner's scope of\npractice. (iii)\n\nThe\nordering/prescribing of drugs is limited to practitioners not excluded from\nparticipating in the medical assistance program. (2)\n\nAll orders for drugs must show the\nordering practitioner's name, address, telephone number, United States Drug\n\nEnforcement Agency (DEA) number (if applicable), and either the practitioner's\nMMIS provider identification number, the practitioner's license number or the\ncertification number of the facility in which the drugs were ordered. All\norders must also contain the name of the recipient for whom ordered. (3)\n\nWhen used in the context of an order for\na prescription drug, the order must also meet the requirements for a\nprescription under section\n6810\nof the\n\nEducation Law and 10 NYCRR Part\n910. When used in the context of a\nnonprescription drug, the order must also contain the following information: name of the drug; quantity ordered; strength or dosage; ingredient information, as necessary; directions for use; date ordered; and number of refills, if\nany. (4)\n\nTelephone orders and for\nprescription drugs permitted to be filled by subdivision (4) of section\n6810\nof the\n\nEducation Law and non-prescription drugs are permitted. (5)\nA telephone order must be recorded by the\npharmacy in the format required by subdivision (4) of section\n6810\nof the\n\nEducation Law, recording the time of the call and the initials of the person\ntaking the call and the dispenser, prior to dispensing the drug. The pharmacist\nmust label the drug as he/she would a written prescription, and make a good\nfaith effort to verify the practitioner's identity, and validity of the\nprescription if the practitioner is unknown to the pharmacist. The practitioner\nmust expressly state whether substitution is permitted or prohibited. (6)\n\nEffective April 1, 2005 an order which\nrequests a pharmacy to provide a drug to a medical assistance recipient may be\nelectronically transmitted unless otherwise prohibited by law or regulation. All written orders and all orders which are electronically transmitted must\ncomply with the relevant provision of the State Education Law and all\nregulations promulgated thereunder. It is the responsibility of the pharmacist\nto make a good faith effort to verify the practitioner's identity and validity\nof the prescription if the practitioner is unknown to the pharmacist. (7)\n\nOn or after June 1, 2005 and after the\ndepartment has provided advance written notice to appropriate providers, all\nclaims for payment of drugs provided under this section and submitted to the\n\nMedical Assistance Program shall contain the serial number of the official New\n\nYork State prescription form. Additionally, where serial numbers are available\non official NYS prescription forms for items not required to be ordered or\nprescribed on such forms, the billing pharmacy provider must enter such serial\nnumbers on pharmacy claims submitted for payment to the MA program. (c) Where obtained. Drugs may be obtained only from pharmacies which are\nproperly registered by the State in which the pharmacy is located, or from the\nordering practitioner. A pharmacy must keep on file the signed written order of\nthe practitioner for audit by the department, or other authorized agency, for\nsix years from the date of payment for any drug dispensed. A practitioner must\nannotate the patient record to reflect the dispensing of the drug and the\nquantity, dose, directions for use and number of refills, if\nany. (d) Prescription\nrefills. (1)\nA written order may not\nbe refilled unless the practitioner has indicated the number of allowable\nrefillings on the order. (2)\n\nNo\nwritten order for drugs may be refilled more than twelve months after the date\nof issuance, nor more than eleven times within a twelve-month period. (3)\n\nRefills must bear the prescription number\nof the original written order. (e) Prescribed quantities. (1)\n\nDrugs must be ordered in a quantity\nconsistent with the health needs of the patient and sound medical\npractice. (2)\n\nDispensing limits for\ndrugs. (i) Except as provided in subparagraph\n(ii) of this paragraph, the maximum quantity of drugs dispensed is limited to\nthe larger of: (a) a 30-day supply; or\n(b) 100 doses. One hundred doses\nis 100 units of a solid formulation. (ii)\n\nThe dispensing limit does not apply to\nlong-term maintenance drugs. Long-term maintenance drugs are: (a) drugs ordered or prescribed with one or\nmore refills in quantities of a 30-day supply or greater. The quantity ordered\nor prescribed must be based on generally accepted medical practice. The\nordering practitioner must be contacted if dispensing the supply specified in\nthe prescription would result in the medical assistance recipient receiving a\nquantity of drugs which exceeds the manufacturer's labeling indications; or\n(b) drugs ordered or prescribed\nwithout refills in quantities of a 60-day supply or greater. The quantity\nordered or prescribed must be based on generally accepted medical practice. The\nordering practitioner must be contacted if dispensing the supply specified in\nthe prescription would result in the medical assistance recipient receiving a\nquantity of drugs which exceeds the manufacturer's labeling indications; or\n(c) drugs ordered or prescribed\nfor family planning purposes. The quantity ordered or prescribed must be based\non generally accepted medical practice. Prescription contraceptives for family\nplanning purposes may be dispensed in a 12-month supply at one time; or\n(d) prescriptions written and\ndispensed on the official New York State prescription form for up to a\nthree-month supply when written in conformity with the Controlled Substance Act\n(title IV of article 33 of the Public Health Law). (f) Payment for\ndrugs. (1)\n\nThe reimbursement amounts\nare payment in full. (2)\n\nDrugs\nprovided by a practitioner and billed separately will be paid for at the actual\ncost to the practitioner. (3)\n\nThe\ndepartment will pay each pharmacy enrolled in the MA program a dispensing fee\nfor each prescription drug claim. Dispensing fees include routine delivery\ncharges. The department will pay an additional compounding fee of $.75 for each\ncompounded prescription drug claim. The additional dispensing fee for a\ncompounded prescription drug claim will not be paid when a manufacturer's\nspecialty drug is reconstituted or when a nonmedical or nontherapeutic agent is\nadded to the prescription drug. (4)\n\nEach pharmacy enrolled in the Medicaid program shall provide the department, in\nsuch manner, for such periods, and at such times as the department may require, with the drug acquisition costs, as defined in paragraph (a)(3) of this\nsection, of prescription drugs. (g) Limitations. (1)\n\nThe department will pay for therapeutic\nvitamins and specific vitamin preparations only when ordered by a physician for\nthe treatment of deficiency states or pathological conditions requiring\nincreased vitamins. (2)\n\nThe\ndepartment will pay for amphetamine and amphetamine-like substances (congeners)\nonly when used in outpatient treatment of conditions other than obesity or\nweight reduction. (3)\n\nNo payment\nwill be made for any drug which has weight reduction as its sole clinical use. Payment for drugs used to promote fertility is limited to bromocriptine, clomiphene citrate, letrozole and tamoxifen, when receiving services pursuant\nto section\n505.1\n(a)(1)(iii)\nof this Part, and subject to the FDA recommended and/or compendia-supported\nuses and limitations. (4)\n\nFrom time\nto time the department may limit the frequency or the amount of drugs which may\nbe ordered. The department may require prior approval or prior authorization of\ndrugs. The department may allow for exceptions to prior approval or prior\nauthorization requirements in emergency circumstances. Emergency circumstances\nfor purposes of this paragraph means any condition requiring alleviation of\nsevere pain or which threatens to cause disability or take life if not promptly\ntreated. The department will advise practitioners and pharmacies in writing\nbefore any reduction in frequency or amount, prior authorization or prior\napproval is imposed on any drug. (h) Utilization threshold. (1)\n\nThis subdivision describes the\nutilization threshold that the department has established for pharmacy\nservices. Part 503 of this Title authorizes the department to establish a\nutilization threshold for specific provider service types, including pharmacy\nservices. Part 503 also describes the application of the utilization threshold, services and procedures excluded from the utilization threshold for all\nprovider service types subject to a threshold, the method for obtaining an\nexemption from or increase in the utilization threshold, notices, and the right\nto a fair hearing in certain situations. (2)\n\nGeneral rules. (i) Federally nonparticipating persons. Payment will be made for up to 43 pharmacy service formulary codes in a benefit\nyear for persons who belong to a group listed in section\n360-3.3\n(a)(1) or\n(b)(7)\nof this Title. (ii)\n\nFederally participating persons. Payment\nwill be made for up to 60 pharmacy service formulary codes in a benefit year\nfor persons who belong to a group listed in section\n360-3.3\n(a)(2)-(6), (b)(1)-(6) or\n(3)\nof this Title. (3)\n\nFormulary codes. As used in this subdivision, a formulary code is defined\nas follows: (i) for prescription drugs, the first time a prescription is filled is one formulary code; each refill of\nthe original prescription is also one formulary code; and\n(ii)\nfor nonprescription drugs and medical\nand surgical supplies, each initial fiscal order for the drug or supply is one\nformulary code; each refill of the fiscal order is also one formulary\ncode. (i) The\ndepartment may, after completing a competitive request for proposal (RFP)\nprocess, contract with mail-order pharmacies or their corporate owners to\nsupply prescription and nonprescription drugs and medical/surgical supplies by\nmail to medical assistance (MA) recipients. The department may elect to offer\nmail-order pharmacy services in one or more social services districts through a\ncontractor selected after completion of the RFP process. Individuals who are\nfurnished MA by such districts who are not restricted in their access to drugs\nor medical/surgical supplies and who are not patients in residential health\ncare facilities or any other facilities which have pharmaceuticals included in\ntheir medical assistance payments may choose to receive long-term maintenance\ndrugs, excepting drugs prohibited pursuant to article 33 of the Public Health\n\nLaw, nonprescription drugs and medical/surgical supplies by mail from\ncontractors selected through the RFP process to provide such drugs and\nsupplies. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 18\nยง\n505.3\n\nAmended, New\n\nYork State Register March 1, 2017/Volume XXXIX, Issue 09, eff. 3/1/2017\n\nAmended\n\nNew\n\nYork State Register November 14, 2018/Volume XL, Issue 46, eff. 11/14/2018\n\nAmended\n\nNew\n\nYork State Register June 5, 2019/Volume XLI, Issue 22, eff. 6/5/2019\n\nAmended\n\nNew\n\nYork State Register June 8, 2022/Volume XLIV, Issue 23, eff. 6/8/2022\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 2747
}